Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of the Molecular Test Xpert MTB/RIF Ultra for Early Detection of Tuberculosis at Primary Health Care Facilities in Georgia: a Parallel Cluster Randomized Controlled Trial

NCT07135622 is registered in ClinicalTrials.gov with Nestani Tukvadze as lead sponsor.

NCT NCT07135622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07135622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of the Molecular Test Xpert MTB/RIF Ultra for Early Detection of Tuberculosis at Primary Health Care Facilities in Georgia: a Parallel Cluster Randomized Controlled Trial
Lead sponsor
Nestani Tukvadze
Phase
Not applicable
Overall status
Completed
Start date
May 27, 2019
Completion date
February 24, 2023
Enrollment
778 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary tb, tuberculosis (tb)